Astrazeneca AZN
NYSE AZN
$163.66 +3.49 (+2.18%)
As of: Sep 14, 2026 · 3:07 PM EDT

Astrazeneca (AZN) Net Income towards Common Stockholders (QoQ) (2009 - 2026)

Analysis

Astrazeneca (AZN) Net Income towards Common Stockholders (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Asml Holding 618.04 Bn 602.06 Bn 5.90 Bn
2 Hsbc Holdings 362.64 Bn 362.64 Bn -
3 General Electric 329.87 Bn 320.52 Bn 6.95 Bn
4 Astrazeneca 253.67 Bn 248.39 Bn 12.86 Bn
5 Citigroup 228.64 Bn -2,073.66 Bn 24.75 Bn
6 Bhp 216.08 Bn 197.54 Bn -
7 Rio Tinto 203.71 Bn 199.33 Bn -
8 Diageo 197.09 Bn 195.06 Bn -
9 Unilever 139.34 Bn 132.31 Bn -
10 Hdfc Bank 117.87 Bn 80.72 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18.60%
Mar 31, 2026 32.42%
Dec 31, 2025 -8.17%
Sep 30, 2025 3.39%
Jun 30, 2025 -15.98%
Mar 31, 2025 94.40%
Dec 31, 2024 4.97%
Sep 30, 2024 -25.84%
Jun 30, 2024 -11.56%
Mar 31, 2024 126.98%
Dec 31, 2023 -30.13%
Sep 30, 2023 -24.42%
Jun 30, 2023 0.83%
Mar 31, 2023 100.11%
Dec 31, 2022 -45.06%
Sep 30, 2022 355.56%
Jun 30, 2022 -6.74%
Mar 31, 2022 196.50%
Dec 31, 2021 -21.21%
Sep 30, 2021 -160.00%